Identification of Inhibitors of human Lactate Dehydrogenase A (LDHA) as Anti-cancer Agents
Identification of Inhibitors of human Lactate Dehydrogenase A (LDHA) as Anti-cancer Agents
批准号:
9205757
负责人:
David Maloney
金额:
$11.4万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
项目要点:筛选了完整的化合物文库,并确定了要开发的铅化学类型。药物化学正在提高LDHA抑制活性,一系列先进的分析正在进行中,以表征这些化合物的细胞活性,并支持领先候选化合物的临床前进展。
在此期间,NCGC与NIH和校外调查人员进行了180多次积极的合作,促进了整个人类疾病范围内的药物发现工作。这些努力已经产生了100多个高通量筛选和近60个药物化学活动,为我们的合作者和一般研究社区提供了丰富的出版物和前景光明的小分子线索。此外,NCGC还承担了一些信息学挑战,以更好地利用现有的药物和疾病目标信息,并为公众提供易于获取的资源,进一步催化人类疾病新疗法的开发。
英文摘要
Project highlights: the full compound library was screened and a lead chemotype was identified for development. Medicinal chemistry is ongoing to improve LDHA inhibitory activity, and a battery of advanced assays are in progress to characterize cellular activity of these compounds and support preclinical advancement of a lead candidate.
During this period, the NCGC has fostered and maintained over 180 active collaborations with both NIH and extramural investigators, facilitating drug discovery efforts across the entire spectrum of human disease. These efforts have led to over 100 high-throughput screens and nearly 60 medicinal chemistry campaigns, providing our collaborators and the general research community a wealth of publications and promising small molecule leads. In addition, the NCGC has undertaken a number of informatic challenges to make better use of existing drug and disease target information and provide the general public with easily accessible resources, further catalyzing the development of new therapies for human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibitors of p53-S100B interaction for melanoma
-
批准号:9205744
-
项目类别:
-
资助金额:$11.4万
-
财政年份:--
-
负责人:David Maloney
-
依托单位:
ML199: Inhibitor of Ape1 as a Lead for Cancer Therapeutics
-
批准号:9205756
-
项目类别:
-
资助金额:$11.4万
-
财政年份:--
-
负责人:David Maloney
-
依托单位:
Implications of 12-Lipoxygenase and NOX-1 in beta-Cell dysfunction, a potential target for Diabetes
-
批准号:9359885
-
项目类别:
-
资助金额:$22.7万
-
财政年份:--
-
负责人:David Maloney
-
依托单位:
Discovery of Inhibitors of Human 5-Lipoxygenase and CYP51 as Anti-Fungal Leads
-
批准号:9205750
-
项目类别:
-
资助金额:$11.4万
-
财政年份:--
-
负责人:David Maloney
-
依托单位:
Selective Inhibitors of ALDH1A1
-
批准号:9359883
-
项目类别:
-
资助金额:$22.7万
-
财政年份:--
-
负责人:David Maloney
-
依托单位:
Assay for Inhibitors of HPGD, 15-hydroxyprostaglandin dehydrogenase
-
批准号:9205752
-
项目类别:
-
资助金额:$11.4万
-
财政年份:--
-
负责人:David Maloney
-
依托单位:
BET Inhibitors as Therapeutics for Oncology
-
批准号:9205758
-
项目类别:
-
资助金额:$11.4万
-
财政年份:--
-
负责人:David Maloney
-
依托单位:
Discovery of ML324, a JMJD2 Demethylase Epigenetic Modulator as Potential Antiviral
-
批准号:9205748
-
项目类别:
-
资助金额:$11.4万
-
财政年份:--
-
负责人:David Maloney
-
依托单位:
Selective Inhibitors of ALDH1A1
-
批准号:9205751
-
项目类别:
-
资助金额:$11.4万
-
财政年份:--
-
负责人:David Maloney
-
依托单位:
海外基金